Active substance
Cromoglicic acid
- SFDA 13
- US FDA 31
- Health Canada 2
- US price lines 4
- NHS prices 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| APICROM 2% EYE DROPS | 2 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 10.60 | NCE · OTC | Amman Pharmaceutical Industries (API) | Valid |
| OPTIDRIN EYE DROP | 2 % | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 15.05 | Generic · OTC | Jamjoom Pharmaceuticals Factory Company | Valid |
| APICROM 4% EYE DROPS | 4 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 14.95 | Generic · Prescription | Amman Pharmaceutical Industries (API) | Withdrawn by MAH · Not Marketed |
| CROMONAL NASAL spray 2% | 2 mg/ml | Nasal spray · Nasal use | 1 Spray Container | SAR 18.05 | Generic · OTC | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| CUSICROM EYE DROPS 2% | 2 % | Eye drops · Ocular use | 1 Dropper Container | SAR 18.00 | NCE · OTC | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| CUSICROM EYE DROPS 4% | 4 % | Eye drops · Ocular use | 1 Dropper Container | SAR 26.30 | NCE · OTC | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| CUSICROM NASAL SPRAY 2% | 2 % | Nasal spray, solution · Nasal use | 1 Spray Container | SAR 19.25 | NCE · OTC | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| DADCROME | 2 % | Eye drops · Ocular use | 1 Dropper Container | SAR 14.35 | Generic · OTC | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| INTAL 5 INHALER | 5 mg | Solution · Inhalation use | 1 Inhaler | SAR 86.65 | Generic · Prescription | sanofi-aventis | Withdrawn by MAH · Not Marketed |
| INTAL NEBULISER SOLN 1% 2ML AMP | 1 % | Solution · Inhalation use | 48 Ampoule | SAR 60.40 | NCE · Prescription | sanofi-aventis | Withdrawn by MAH · Not Marketed |
| VISACROM 2% EYE DROPS | 2 % | Eye drops · Ocular use | 1 Dropper Container | SAR 18.35 | Generic · OTC | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| VISACROM 4% EYE DROPS | 4 % | Eye drops · Ocular use | 1 Dropper Container | SAR 27.75 | Generic · OTC | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| VIVIDRIN 2% EYE DROPS | 2 % | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 19.20 | Generic · OTC | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| GASTROCROM | 100MG/5ML | concentrate · oral | VIATRIS SPECIALTY | Prescription | 29 Feb 1996 |
| CROMOLYN SODIUM | 4% | solution/drops · ophthalmic | SANDOZ | Prescription | 16 Jun 1999 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | WOCKHARDT BIO AG | Prescription | 25 Oct 1999 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | TEVA PHARMS | Prescription | 18 Jan 2000 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | SCIEGEN PHARMS | Prescription | 21 Apr 2000 |
| CROMOLYN SODIUM | 5.2MG/SPRAY | spray, metered · nasal | BAUSCH AND LOMB | Over-the-counter | 3 Jul 2001 |
| CROMOLYN SODIUM | 100MG/5ML | concentrate · oral | RISING | Prescription | 27 Oct 2011 |
| CROMOLYN SODIUM | 100MG/5ML | concentrate · oral | MICRO LABS LTD INDIA | Prescription | 4 Apr 2013 |
| CROMOLYN SODIUM | 100MG/5ML | concentrate · oral | AILEX PHARMS LLC | Prescription | 16 Oct 2017 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | AILEX PHARMS LLC | Prescription | 16 Oct 2017 |
| INTAL | 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · inhalation | KING PHARMS LLC | Discontinued | 28 May 1982 |
| OPTICROM | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution/drops · ophthalmic | ALLERGAN | Discontinued | 3 Oct 1984 |
| INTAL | 0.8MG/INH | aerosol, metered · inhalation | KING PHARMS LLC | Discontinued | 5 Dec 1985 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | EUGIA PHARMA | Discontinued | 26 Apr 1994 |
| CROLOM | 4% | solution/drops · ophthalmic | BAUSCH AND LOMB | Discontinued | 30 Jan 1995 |
| NASALCROM | 5.2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | spray, metered · nasal | BLACKSMITH BRANDS | Discontinued | 3 Jan 1997 |
| CROMOLYN SODIUM | 4% | solution/drops · ophthalmic | SCIEGEN PHARMS | Discontinued | 29 Apr 1998 |
| CROMOPTIC | 4% | solution/drops · ophthalmic | KING PHARMS | Discontinued | 27 Apr 1999 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | ACTAVIS MID ATLANTIC | Discontinued | 19 Jul 1999 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | ROXANE | Discontinued | 30 Sep 1999 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | BAUSCH | Discontinued | 21 Dec 2000 |
| CROMOLYN SODIUM | 4% | solution/drops · ophthalmic | APOTEX INC | Discontinued | 26 Jan 2001 |
| CROMOLYN SODIUM | 5.2MG/SPRAY | spray, metered · nasal | ACTAVIS MID ATLANTIC | Discontinued | 26 Jul 2001 |
| CROMOLYN SODIUM | 5.2MG/SPRAY | spray, metered · nasal | PERRIGO | Discontinued | 12 Dec 2001 |
| CROMOLYN SODIUM | 10MG/ML | solution · inhalation | HIKMA PHARMS | Discontinued | 30 Apr 2002 |
6 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CROMOLYN EYE DROPS | 02009277 | 2 % | SOLUTION · OPHTHALMIC | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| NALCROM | 00500895 | 100 MG | CAPSULE · ORAL | LUPIN PHARMA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CROMOLYN 100 MG/5 ML ORAL CONC | $0.34899 | per ML | 23 Sep 2026 |
| US NADAC | CROMOLYN 20 MG/2 ML NEB SOLN | $0.96262 | per ML | 23 Sep 2026 |
| US NADAC | CROMOLYN 4% EYE DROPS | $0.59532 | per ML | 23 Sep 2026 |
| US NADAC | GASTROCROM 100 MG/5 ML CONC | $2.43248 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Sodium cromoglicate 100mg capsules | £152.67 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Sodium cromoglicate 100mg/5ml oral solution 5ml unit dose ampoules sugar free | £121.86 | 96 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Sodium cromoglicate 2% eye drops | £2.15 | 13.5 ml | 1 Oct 2026 |
| NHS Drug Tariff | Sodium cromoglicate 2% eye drops 0.3ml unit dose preservative free | £11.99 | 30 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Sodium cromoglicate 2% eye drops preservative free | £3.80 | 10 ml | 1 Oct 2026 |
| NHS Drug Tariff | Sodium cromoglicate 2% eye drops preservative free | £8.03 | 13.5 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Cromoglicic acid
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.